The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Altering the Tropism of Lentiviral Vectors through Pseudotyping
Cronin, J., Zhang, X.-Y., & Reiser, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054546224 · Cited by 536
Self-citationCoordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters
Amendola, M., Venneri, M. A., Biffi, A., Vigna, E., & Naldini, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1049 · Cited by 324
Akkina, R. K., Walton, R. M., Chen, M. L., Li, Q. X., Planelles, V, & Chen, I. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2581-2585.1996 · Cited by 321
Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O., & Reiser, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8873-8883.1998 · Cited by 308
Self-citationTransduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles
Reiser, J., Harmison, G., Kluepfel-Stahl, S., Brady, R. O., Karlsson, S., & Schubert, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15266 · Cited by 307
Self-citationTitering lentiviral vectors: comparison of DNA, RNA and marker expression methods
Sastry, L., Johnson, T., Hobson, M. J., Smucker, B., & Cornetta, K. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301731 · Cited by 295
Optimized large-scale production of high titer lentivirus vector pseudotypes
Sena-Esteves, M., Tebbets, J. C., Steffens, S., Crombleholme, T., & Flake, A. W. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.08.017 · Cited by 289
[26] Generation of HIV-1 derived lentiviral vectors
Follenzi, A., & Naldini, L. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)46071-5 · Cited by 199
Production and concentration of pseudotyped HIV-1-based gene transfer vectors
Reiser, J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301188 · Cited by 175
Self-citation
Cited by
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., et al. (2016) · Nature · doi:10.1038/nature20565 · Cited by 1,150
Kloss, C. C., Lee, J., Zhang, A., Chen, F., Melenhorst, J. J., Lacey, S. F., Maus, M. V., Fraietta, J. A., Zhao, Y., & June, C. H. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.003 · Cited by 648
Production of lentiviral vectors
Merten, O.-W., Hebben, M., & Bovolenta, C. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.17 · Cited by 294
Jurado, K. A., Wang, H., Slaughter, A., Feng, L., Kessl, J. J., Koh, Y., Wang, W., Ballandras-Colas, A., Patel, P. A., Fuchs, J. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300703110 · Cited by 203
Gascon, E., Lynch, K., Ruan, H., Almeida, S., Verheyden, J. M., Seeley, W. W., Dickson, D. W., Petrucelli, L., Sun, D., Jiao, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3717 · Cited by 183
Rowan, B. G., Gimble, J. M., Sheng, M., Anbalagan, M., Jones, R. K., Frazier, T. P., Asher, M., Lacayo, E. A., Friedlander, P. L., Kutner, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089595 · Cited by 174
Self-citationRequirement for CDK6 in MLL-rearranged acute myeloid leukemia
Placke, T., Faber, K., Nonami, A., Putwain, S. L., Salih, H. R., Heidel, F. H., Krämer, A., Root, D. E., Barbie, D. A., Krivtsov, A. V., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558114 · Cited by 170
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β A(T87Q) - Globin Gene
Negre, O., Eggimann, A.-V., Beuzard, Y., Ribeil, J.-A., Bourget, P., Borwornpinyo, S., Hongeng, S., Hacein-Bey, S., Cavazzana, M., Leboulch, P., et al. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.007 · Cited by 159
The HIF-1/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia
Koh, H. S., Chang, C. Y., Jeon, S.-B., Yoon, H. J., Ahn, Y.-H., Kim, H.-S., Kim, I.-H., Jeon, S. H., Johnson, R. S., & Park, E. J. (2015) · Nature Communications · doi:10.1038/ncomms7340 · Cited by 141
Brimer, N., Lyons, C., Wallberg, A. E., & Vande Pol, S. B. (2012) · Oncogene · doi:10.1038/onc.2011.589 · Cited by 133
Negre, O., Bartholomae, C., Beuzard, Y., Cavazzana, M., Christiansen, L., Courne, C., Deichmann, A., Denaro, M., Dreuzy, E., Finer, M., et al. (2014) · Current Gene Therapy · doi:10.2174/1566523214666141127095336 · Cited by 126
Self-citationHuman germline heterozygous gain-of-function STAT6 variants cause severe allergic disease
Sharma, M., Leung, D., Momenilandi, M., Jones, L. C. W., Pacillo, L., James, A. E., Murrell, J. R., Delafontaine, S., Maimaris, J., Vaseghi-Shanjani, M., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20221755 · Cited by 125
mGluR5 in the nucleus accumbens is critical for promoting resilience to chronic stress
Shin, S., Kwon, O., Kang, J. I., Kwon, S., Oh, S., Choi, J., Kim, C. H., & Kim, D. G. (2015) · Nature Neuroscience · doi:10.1038/nn.4028 · Cited by 125
Chen, J., Harding, S. M., Natesan, R., Tian, L., Benci, J. L., Li, W., Minn, A. J., Asangani, I. A., & Greenberg, R. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108080 · Cited by 111
Thalamic neuropeptide mediating the effects of nursing on lactation and maternal motivation
Cservenák, M., Szabó, É. R., Bodnár, I., Lékó, A., Palkovits, M., Nagy, G. M., Usdin, T. B., & Dobolyi, A. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.004 · Cited by 77
Yang, R., Huang, B., A, R., Li, W., Wang, W., Deng, Y., & Tan, W. (2020) · Biosafety and Health · doi:10.1016/j.bsheal.2020.08.004 · Cited by 70
Enhanced production of exosome-associated AAV by overexpression of the tetraspanin CD9
Schiller, L. T., Lemus-Diaz, N., Rinaldi Ferreira, R., Böker, K. O., & Gruber, J. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.03.008 · Cited by 63
“Functional Virus Quantification The transducing units (TUs) of AAV1 were determined by a transduction assay modified from Kutner et al.34 HEK cells were seeded in 24-well plates and transfected at the next day with a 2:5 serial dilution of the virus in OptiMEM (GIBCO, Life Technology, Darmstadt, Germany) supplemented…”
MethodPooled genetic perturbation screens with image-based phenotypes
Feldman, D., Funk, L., Le, A., Carlson, R. J., Leiken, M. D., Tsai, F., Soong, B., Singh, A., & Blainey, P. C. (2022) · Nature Protocols · doi:10.1038/s41596-021-00653-8 · Cited by 59
The protective effect of microRNA-21 in neurons after spinal cord injury
Zhang, T., Ni, S., Luo, Z., Lang, Y., Hu, J., & Lu, H. (2019) · Spinal Cord · doi:10.1038/s41393-018-0180-1 · Cited by 59
Calcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P., O’Brien, T., Taylor, A., & Bieback, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03352-1 · Cited by 56
“Lentiviral particles were produced using standard protocols [18] by co-transfection of HEK cells with the transfer vector (pHIV-Luc2-ZsGreen), an envelope plasmid (pMD2.”
MethodManu, K. A., Chai, T. F., Teh, J. T., Zhu, W. L., Casey, P. J., & Wang, M. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0703 · Cited by 55
Replication-competent Lentivirus Analysis of Clinical Grade Vector Products
Cornetta, K., Yao, J., Jasti, A., Koop, S., Douglas, M., Hsu, D., Couture, L. A., Hawkins, T., & Duffy, L. (2011) · Molecular Therapy · doi:10.1038/mt.2010.278 · Cited by 55
Process for an efficient lentiviral cell transduction
Pirona, A. C., Oktriani, R., Boettcher, M., & Hoheisel, J. D. (2020) · Biology Methods and Protocols · doi:10.1093/biomethods/bpaa005 · Cited by 31
Chai, T. F., Manu, K. A., Casey, P. J., & Wang, M. (2020) · Oncogene · doi:10.1038/s41388-020-1364-7 · Cited by 20
Bradberry, M. M., & Chapman, E. R. (2022) · The Journal of Physiology · doi:10.1113/jp282601 · Cited by 16
Prominin 1 and Tweety Homology 1 both induce extracellular vesicle formation
(2024) · doi:10.7554/elife.100061 · Cited by 7
CCDC32 stabilizes clathrin-coated pits and drives their invagination
Yang, Z., Yang, C., Huang, Z., Xu, P., Li, Y., Han, L., Peng, L., Wei, X., Pak, J. E., Svitkina, T., et al. (2026) · eLife · doi:10.7554/elife.107039.3 · Cited by 3
Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy
Wu, C., Johnson, N. M., Yu, S., Lo, A. S., Sahu, G. K., Marx, P. A., von Laer, D., Skowron, G., Geleziunas, R., Shaw, G. M., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01933-24 · Cited by 2
CCDC32 stabilizes clathrin-coated pits and drives their invagination
Yang, Z., Yang, C., Huang, Z., Xu, P., Li, Y., Han, L., Peng, L., Wei, X., Pak, J. E., Svitkina, T., et al. (2026) · eLife · doi:10.7554/elife.107039
Metadata
- Authors
- Kutner, R. H., Zhang, X.-Y., & Reiser, J.
- Venue
- Nature Protocols
- Published
- 2009-03-19
- Volume
- 4
- Issue
- 4
- Pages
- 495-505
- ISSN
- 1750-2799 (ISSN-L)
- 1754-2189
- OpenAlex
- W2059038945
- Cited by
- 668
- References
- 23
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.